Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector 2024-01-04 17:37
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry 2024-01-04 16:55
Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH/Liver Fibrosis at NASH-TAG 2024 2024-01-04 12:40
IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies 2024-01-04 05:30
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN 2024-01-04 04:30
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development 2024-01-03 09:28
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology 2024-01-02 22:00
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference 2024-01-02 11:58
TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data 2023-12-29 21:00
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 2023-12-27 11:49
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site 2023-12-27 11:37
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs 2023-12-26 17:26
PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development 2023-12-26 11:00
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia 2023-12-24 17:53
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma 2023-12-21 21:45
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors 2023-12-21 01:00
Genevoyager Unveils Gene Therapy CDMO Facility in Milestone Move 2023-12-20 23:10
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum 2023-12-20 20:00
InxMed Enters License Agreement with Escugen to Develop Next-Generation ADCs 2023-12-20 09:00
1 28 29 30 31 32 165